Back
Viking Therapeutics, Inc. Stock Predictions
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
38
VKTX
Viking Therapeutics, Inc.
Last Price:
$32.24
Seasonality Move:
20.01%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assetsViking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 57% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $32.22. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 57% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
38
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.15
52-Week Low:
18.92
Prediction Charts
Market Cap:
3.6B
Price in USD:
32.22
Volume:
2.8M
Beta:
1.33
Technical Analysis
SMA50:
35.43
SMA100:
32.97
SMA200:
30.92
52-Wk Change:
-7.78%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 32.22 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-5 | 35.20 | 32.14 | 35.21 | 31.85 |
| Jan-6 | 31.88 | 32.30 | 33.28 | 31.56 |
| Jan-7 | 32.50 | 32.38 | 33.35 | 31.73 |
| Jan-8 | 32.30 | 31.65 | 32.30 | 31.59 |
| Jan-9 | 32.35 | 31.99 | 32.94 | 31.79 |
| Jan-12 | 32.33 | 31.76 | 32.33 | 31.04 |
| Jan-13 | 31.69 | 30.69 | 31.82 | 29.54 |
| Jan-14 | 30.69 | 34.34 | 36.00 | 30.56 |
| Jan-15 | 34.36 | 31.88 | 34.90 | 31.86 |
| Jan-16 | 31.98 | 33.92 | 34.28 | 31.71 |
| Jan-20 | 32.78 | 33.52 | 34.06 | 32.56 |
| Jan-21 | 33.63 | 33.38 | 33.98 | 32.42 |
| Jan-22 | 33.45 | 34.09 | 34.99 | 33.26 |
| Jan-23 | 33.81 | 32.22 | 34.41 | 32.05 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.28 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.